Literature DB >> 8138892

Physiological pharmacokinetics of solutes in the isolated perfused rat hindlimb: characterization of the physiology with changing perfusate flow, protein content, and temperature using statistical moment analysis.

Z Y Wu1, L P Rivory, M S Roberts.   

Abstract

Distribution of Evans Blue (EB), sucrose, and water into the isolated perfused rat hindlimb was studied under various conditions using the multiple indicator dilution (MID) technique. Statistical moment analysis of the outflow profiles for the EB, sucrose, and water were used to define the vascular, extravascular, and total water spaces, respectively. The varied perfusion conditions included albumin content (2, 4.7, and 7%), temperature (25, 37, and 42 C), perfusate flow rate (2, 4, 8, and 12 ml/min) and the presence/absence of red blood cells. The range of studies undertaken were chosen to represent the variety of conditions used in the preparation of both isolated animal and human limbs, the latter being particularly important in cytotoxic therapy for recurrent malignant melanoma. The distribution volumes of EB, sucrose, and water were dependent on the flow rate and the albumin content of perfusate. The normalized variances (CV2) of the markers were of the following order: sucrose (2.18) > water (1.58) > EB (0.68), indicating that some disequilibrium occurs during the capillary exchange of water and sucrose. It is suggested that a Krebs-Henseleit buffer containing 2% BSA is a suitable perfusate for most studies of the isolated rat hindlimb perfusion. The effect of albumin concentration manifests itself only at higher flows.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8138892     DOI: 10.1007/bf01113500

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  47 in total

1.  Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit.

Authors:  O CREECH; E T KREMENTZ; R F RYAN; J N WINBLAD
Journal:  Ann Surg       Date:  1958-10       Impact factor: 12.969

2.  Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future.

Authors:  B B Kroon
Journal:  Eur J Surg Oncol       Date:  1988-04       Impact factor: 4.424

Review 3.  Permeability of continuous capillaries.

Authors:  W P Paaske; P Sejrsen
Journal:  Dan Med Bull       Date:  1989-12

4.  Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).

Authors:  Y Yano; K Yamaoka; Y Aoyama; H Tanaka
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

5.  Capillary permeability in skeletal muscle.

Authors:  W P Paaske
Journal:  Acta Physiol Scand       Date:  1977-09

6.  Perfusion of the isolated rat hindlimb with a synthetic medium.

Authors:  P Strohfeldt; H Kettl; K F Weinges
Journal:  Horm Metab Res       Date:  1974-03       Impact factor: 2.936

7.  Pharmacokinetics of melphalan in clinical isolation perfusion of the extremities.

Authors:  H A Briele; M Djuric; D T Jung; T Mortell; M K Patel; T K Das Gupta
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

8.  Higher albumin clearance in rat hindquarters perfused with pure albumin solution than with serum as perfusate.

Authors:  B Haraldsson; B Rippe
Journal:  Acta Physiol Scand       Date:  1984-09

9.  Lactate metabolism in the perfused rat hindlimb.

Authors:  M Shiota; S Golden; J Katz
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

10.  Inhibition by vasodilators of noradrenaline and vasoconstrictor-mediated, but not skeletal muscle contraction-induced oxygen uptake in the perfused rat hindlimb; implications for non-shivering thermogenesis in muscle tissue.

Authors:  E Q Colquhoun; M Hettiarachchi; J M Ye; S Rattigan; M G Clark
Journal:  Gen Pharmacol       Date:  1990
View more
  10 in total

1.  An isolated in-situ rat head perfusion model for pharmacokinetic studies.

Authors:  K A Foster; G D Mellick; M Weiss; M S Roberts
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Distribution and binding kinetics of ciprofloxacin and ofloxacin in the hindlimb of the rat.

Authors:  A Sanchez-Navarro; A C Casquero-Dorado; M Weiss
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

3.  Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Authors:  Peng Li; Thomas A Robertson; Qian Zhang; Linda M Fletcher; Darrell H G Crawford; Michael Weiss; Michael S Roberts
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

4.  Characterization of the physiological spaces and distribution of tolbutamide in the perfused rat pancreas.

Authors:  Kent John Fanning; Michael S Roberts
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

5.  Discrepancies in pharmacokinetic parameter estimation between bolus and infusion studies in the perfused rat hindlimb.

Authors:  A C Heatherington; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

6.  A physiologically based pharmacokinetic model incorporating dispersion principles to describe solute distribution in the perfused rat hindlimb preparation.

Authors:  R E Oliver; A C Heatherington; A F Jones; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

7.  Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb.

Authors:  M Weiss; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

8.  A physiological pharmacokinetic model for solute disposition in tissues below a topical below a topical application site.

Authors:  M S Roberts; S E Cross
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

Review 9.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

10.  The effects of perfusion conditions on melphalan distribution in the isolated perfused rat hindlimb bearing a human melanoma xenograft.

Authors:  Z Y Wu; B M Smithers; P G Parsons; M S Roberts
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.